CalOptima CEO to retire

Advertisement

CalOptima Health CEO Michael Hunn is retiring on Dec. 31, 2026. 

Mr. Hunn was named interim CEO of the insurer in 2021 and CEO in 2022. His accomplishments include creating street medicine programs, establishing a department dedicated to implementing CalAIM benefits, and leading the organization toward the launch of marketplace coverage. CalOptima serves more than 870,000 low-income enrollees in Orange County, Calif.

“I am proud of everything we have achieved at CalOptima Health over the past five years, and I will remain fully committed and focused through the end of the year,” Mr. Hunn said in a Jan. 22 news release. “We have reinvigorated CalOptima Health and reestablished our plan as a trusted community partner that serves members with dignity and respect. Together with CalOptima Health’s Board of Directors, executive leaders, staff and numerous Orange County leaders, we have made a difference in the community and fulfilled the mission to serve members. We just celebrated our 30-year anniversary, and our commitment to quality care for those most in need has never been stronger.”

Prior to joining CalOptima, Mr. Hunn was president and founder of a healthcare consulting firm. He also has more than 25 years of executive leadership experience in CEO and president roles with hospitals and health systems.

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Executive Moves

  • The Blue Cross Blue Shield Association has tapped Daniel Serrano to serve as CFO. The president and CEO of the…

  • Healthcare analytics company Cotiviti has named Erin Schmuker COO.  Ms. Schmuker joins Cotiviti from Optum, where she most recently served…

  • Molina Healthcare of Ohio’s COO, Holly Saelens, has left her role. According to a September LinkedIn post, Ms. Saelens said…

Advertisement